Coffee Break iconCoffee Break

Coffee Break

Mar 23, 2021 5:30pm ‐ Mar 23, 2021 5:40pm
Genomic and Epigenomic Studies of Cholangiocarcinoma and their Clinical Implications iconGenomic and Epigenomic Studies of Cholangiocarcinoma and their Clinical Implications

Genomic and Epigenomic Studies of Cholangiocarcinoma and their Clinical Implications

Mar 23, 2021 5:40pm ‐ Mar 23, 2021 6:10pm
Immune Therapies for HCC: is NASH-HCC Responding Different iconImmune Therapies for HCC: is NASH-HCC Responding Different

Immune Therapies for HCC: is NASH-HCC Responding Different

Mar 23, 2021 6:10pm ‐ Mar 23, 2021 6:40pm
Short Talk: Heterogeneous Liver Cancer Development Promoted by PTEN Regulated beta-Catenin and SOX9 Signal iconShort Talk: Heterogeneous Liver Cancer Development Promoted by PTEN Regulated beta-Catenin and SOX9 Signal

Short Talk: Heterogeneous Liver Cancer Development Promoted by PTEN Regulated beta-Catenin and SOX9 Signal

Mar 23, 2021 6:40pm ‐ Mar 23, 2021 6:55pm
Short Talk: Gender Distinct in Genomic Features of HBV-Related Hepatocellular Carcinoma iconShort Talk: Gender Distinct in Genomic Features of HBV-Related Hepatocellular Carcinoma

Short Talk: Gender Distinct in Genomic Features of HBV-Related Hepatocellular Carcinoma

Mar 23, 2021 6:55pm ‐ Mar 23, 2021 7:10pm
Immunotherapies for Hepatobiliary Cancers: Current Status and Future Perspectives iconImmunotherapies for Hepatobiliary Cancers: Current Status and Future Perspectives

Immunotherapies for Hepatobiliary Cancers: Current Status and Future Perspectives

Mar 24, 2021 9:00am ‐ Mar 24, 2021 9:30am
Advances in Molecular and Immune Targeting of Hepatobiliary Cancers iconAdvances in Molecular and Immune Targeting of Hepatobiliary Cancers

Advances in Molecular and Immune Targeting of Hepatobiliary Cancers

Mar 24, 2021 9:00am ‐ Mar 24, 2021 12:05pm
Developing Clinical Trials of Novel Therapeutic Agents and Treatment Combinations for Intrahepatic Cholangiocarcinoma iconDeveloping Clinical Trials of Novel Therapeutic Agents and Treatment Combinations for Intrahepatic Cholangiocarcinoma

Developing Clinical Trials of Novel Therapeutic Agents and Treatment Combinations for Intrahepatic Cholangiocarcinoma

Mar 24, 2021 9:30am ‐ Mar 24, 2021 10:00am
Targeted Agent and Immune-Based Therapies for Hepatocellular Carcinoma iconTargeted Agent and Immune-Based Therapies for Hepatocellular Carcinoma

Targeted Agent and Immune-Based Therapies for Hepatocellular Carcinoma

Mar 24, 2021 10:00am ‐ Mar 24, 2021 10:30am
Coffee Break iconCoffee Break

Coffee Break

Mar 24, 2021 10:30am ‐ Mar 24, 2021 10:40am